The CDC Won’t Give the Public a Full Picture of Fertility Treatment Risks
By Jackie Davalos, Rachel Adams-Heard, and Kendall Taggart,
Bloomberg
| 01. 24. 2025
For women in the US seeking fertility treatment or considering donating their eggs, there’s a fair amount of information they can find about any given clinic or hospital. They might look for data on how many egg retrievals the clinic has done or the ages of its patients. Many times they’ll want to know how often treatment resulted in the birth of a baby.
But one thing they won’t be able to find out is how often the procedure has gone wrong. That’s because while the Centers for Disease Control and Prevention discloses “success rates,” it keeps information about health complications under lock and key.
The data gap is particularly troubling at a time when fertility treatment is increasingly relying on eggs from donors. As egg-freezing technology has advanced, the number of in vitro fertilization cycles using donor eggs has grown more than 170% since 2000, catapulting the egg-banking and donation sector into a $2 billion business in the US, according to investment firm Harris Williams. In December, Bloomberg Businessweek chronicled how a burgeoning global market for human eggs can lead...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...